A.M. Vitals: FDA Panel Votes to Strip Avastin’s Breast Cancer Indication
Also: Harvard Med School tightens its rules on faculty-industry involvement; WellPoint exec leaves; Chamber of Commerce sets up health-overhaul complaint site.
Read more this great post here
